H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options
The 2021 World Health Organization Classification of Tumors of the Central Nervous System reflected advances in understanding of the roles of oncohistones in gliomagenesis with the introduction of the H3.3-G34R/V mutant glioma to the already recognized H3-K27M altered glioma, which represent the dia...
Main Authors: | Anthony V. Nguyen, Jose M. Soto, Sarah-Marie Gonzalez, Jennifer Murillo, Eric R. Trumble, Frank Y. Shan, Jason H. Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/7/2002 |
Similar Items
-
Case Report: Evolutionary Clinical-Radiological Features of a Diffuse Hemispheric Glioma, H3 G34 Mutant with Over 5 Years of Survival
by: Camilla A.F. Yamada, et al.
Published: (2023-04-01) -
H3G34-mutant diffuse hemispheric glioma with osseous metastases: a case report and literature review
by: Nina Yu, et al.
Published: (2023-06-01) -
Method for the Intraoperative Detection of IDH Mutation in Gliomas with Differential Mobility Spectrometry
by: Ilkka Haapala, et al.
Published: (2022-05-01) -
Survival Analysis and Correlates with Molecular Epidemiology: 10-year Retrospective Series of High-Grade Glioma in Pakistan
by: Mashal Shah, et al.
Published: (2023-12-01) -
Visual Outcome for Children with Optic Pathway Gliomas Treated with Systemic Chemotherapy
by: Mohammad M, et al.
Published: (2022-09-01)